News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,399 Results
Type
Article (18395)
Company Profile (38)
Press Release (471960)
Multimedia
Podcasts (48)
Webinars (14)
Section
Business (154993)
Career Advice (1325)
Deals (26464)
Drug Delivery (43)
Drug Development (48306)
Employer Resources (100)
FDA (9841)
Job Trends (10331)
News (242471)
Policy (17141)
Tag
2027 Bio NC Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1773)
Academic (2)
Accelerated approval (23)
Adcomms (6)
Allergies (85)
Alliances (34685)
ALS (100)
Alzheimer's disease (1058)
Antibody-drug conjugate (ADC) (291)
Approvals (10226)
Artificial intelligence (434)
Autoimmune disease (166)
Automation (38)
Bankruptcy (247)
Best Places to Work (8161)
BIOSECURE Act (13)
Biosimilars (143)
Biotechnology (24)
Bladder cancer (141)
Brain cancer (36)
Breast cancer (467)
Cancer (3477)
Cardiovascular disease (254)
Career advice (1178)
Career pathing (30)
CAR-T (151)
CDC (16)
Celiac Disease (1)
Cell therapy (428)
Cervical cancer (32)
Clinical research (42549)
Collaboration (1313)
Company closure (1)
Compensation (587)
Complete response letters (33)
COVID-19 (1169)
CRISPR (59)
C-suite (903)
Cystic fibrosis (96)
Data (4723)
Decentralized trials (2)
Denatured (13)
Depression (78)
Dermatology (40)
Diabetes (284)
Diagnostics (4516)
Digital health (30)
Diversity (7)
Diversity, equity & inclusion (24)
Drug discovery (177)
Drug pricing (71)
Drug shortages (13)
Duchenne muscular dystrophy (171)
Earnings (69437)
Editorial (28)
Employer branding (14)
Employer resources (93)
Events (73226)
Executive appointments (951)
FDA (12141)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1051)
Gene editing (130)
Generative AI (31)
Gene therapy (345)
GLP-1 (440)
Government (1594)
Grass and pollen (5)
Guidances (373)
Healthcare (11774)
HIV (54)
Huntington's disease (20)
IgA nephropathy (75)
Immunology and inflammation (108)
Immuno-oncology (43)
Indications (101)
Infectious disease (1357)
Inflammatory bowel disease (129)
Inflation Reduction Act (8)
Influenza (79)
Intellectual property (163)
Interviews (206)
IPO (11684)
IRA (18)
Job creations (2397)
Job search strategy (1002)
JPM (35)
Kidney cancer (10)
Labor market (70)
Layoffs (335)
Leadership (27)
Legal (4124)
Liver cancer (60)
Longevity (15)
Lung cancer (425)
Lymphoma (261)
Machine learning (39)
Management (40)
Manufacturing (631)
MASH (117)
Medical device (9329)
Medtech (9391)
Mergers & acquisitions (15746)
Metabolic disorders (701)
mRNA (78)
Multiple sclerosis (128)
NASH (7)
Neurodegenerative disease (206)
Neuropsychiatric disorders (56)
Neuroscience (1862)
NextGen: Class of 2026 (4120)
Non-profit (2437)
Now hiring (31)
Obesity (277)
Opinion (143)
Ovarian cancer (140)
Pain (124)
Pancreatic cancer (172)
Parkinson's disease (179)
Partnered (18)
Patents (308)
Patient recruitment (389)
Peanut (29)
People (50301)
Pharmaceutical (16)
Pharmacy benefit managers (18)
Phase 1 (13346)
Phase 2 (18285)
Phase 3 (14080)
Pipeline (5751)
Policy (99)
Postmarket research (1518)
Preclinical (5759)
Press Release (48)
Prostate cancer (191)
Psychedelics (14)
Radiopharmaceuticals (194)
Rare diseases (586)
Real estate (4276)
Recruiting (42)
Regulatory (14196)
Reports (26)
Research institute (1533)
Resumes & cover letters (183)
Rett syndrome (35)
RNA editing (8)
RSV (49)
Schizophrenia (99)
Series A (167)
Series B (121)
Service/supplier (4)
Sickle cell disease (61)
Special edition (14)
Spinal muscular atrophy (84)
Sponsored (21)
Startups (2476)
Stomach cancer (7)
Supply chain (74)
Tariffs (40)
The Weekly (34)
Vaccines (500)
Venture capital (50)
Weight loss (141)
Women's health (75)
Worklife (15)
Date
Last 7 days (484)
Last 30 days (1635)
Last 365 days (19523)
2026 (6814)
2025 (19784)
2024 (22355)
2023 (26888)
2022 (35557)
2021 (38696)
2020 (37422)
2019 (31160)
2018 (23776)
2017 (21198)
2016 (21014)
2015 (24353)
2014 (17862)
2013 (14202)
2012 (19755)
2011 (19608)
2010 (20142)
Location
Africa (453)
Alabama (52)
Alaska (5)
Arizona (220)
Arkansas (12)
Asia (26377)
Australia (3773)
California (8775)
Canada (2473)
China (734)
Colorado (353)
Connecticut (362)
Delaware (303)
Europe (61306)
Florida (1127)
Georgia (261)
Hawaii (3)
Idaho (46)
Illinois (721)
India (60)
Indiana (359)
Iowa (19)
Japan (426)
Kansas (101)
Kentucky (17)
Louisiana (24)
Maine (69)
Maryland (842)
Massachusetts (6018)
Michigan (274)
Minnesota (419)
Mississippi (6)
Missouri (75)
Montana (12)
Nebraska (21)
Nevada (77)
New Hampshire (72)
New Jersey (2329)
New Mexico (9)
New York (2404)
North Carolina (1055)
North Dakota (9)
Northern California (4316)
Ohio (237)
Oklahoma (10)
Oregon (26)
Pennsylvania (1417)
Puerto Rico (23)
Rhode Island (33)
South America (747)
South Carolina (35)
Southern California (3552)
Tennessee (170)
Texas (1262)
United States (29855)
Utah (172)
Vermont (1)
Virginia (158)
Washington D.C. (51)
Washington State (798)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
490,399 Results for "rutgers business school camden".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
Emergent BioSolutions Inc. announced that it has entered into a definitive agreement to sell its drug product facility in Baltimore-Camden to an affiliate of Bora Pharmaceuticals Co., Ltd., a leading international pharmaceutical services company, for a total value of approximately $30 million.
June 20, 2024
·
4 min read
Press Releases
Rutgers Cancer Institute and RWJBarnabas Health to Showcase Practice-Changing Blood Cancer Research at the 67th American Society of Hematology Annual Meeting and Exposition
December 3, 2025
·
7 min read
Press Releases
Cellares and University of Wisconsin School of Medicine and Public Health Expand Partnership to Clinical Manufacturing of CRISPR-Edited CAR-T for Solid Tumors
February 18, 2026
·
4 min read
Press Releases
Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University
December 16, 2025
·
12 min read
Press Releases
Butterfly Network and Rutgers Robert Wood Johnson Medical School Reveal Preliminary Findings from Seminal Study on Impact of POCUS in Hospital Care
January 13, 2025
·
3 min read
Press Releases
Landmark Data from Rutgers Cancer Institute and RWJBarnabas Health Show Long-term Complete Responses of T Cell Therapies for HPV-Related Cancers
November 10, 2025
·
7 min read
Press Releases
Stellaromics Expands Pyxa™ 3D Spatial Transcriptomics Beta Program with Installation at Emory University School of Medicine
January 29, 2026
·
3 min read
Press Releases
Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer
September 23, 2025
·
6 min read
Press Releases
Etienna Bio Secures Exclusive Worldwide License from UMass Chan Medical School for Novel Adipose-Derived Regenerative Platform
January 12, 2026
·
2 min read
Press Releases
NanoNewron and its Research to Advance the Treatment of Alzheimer’s Disease are Featured by Rutgers University Newsletters and on Rutgers Today
February 21, 2025
·
5 min read
1 of 49,040
Next
